We are live on ! Find out more
MRKR icon

Marker Therapeutics
MRKR

35 hedge funds and large institutions have $5.07M invested in Marker Therapeutics in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

0.85% less ownership

Funds ownership: 24.26% → 23.41% (-0.85%)

3% less funds holding

Funds holding: 36 → 35 (-1)

16% less capital invested

Capital invested by funds: $6.03M → $5.07M (-$954K)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$81.9K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$77.4K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$48.5K
4
TSS
Two Sigma Securities
New York
+$18.2K
5
ATPW
Ashton Thomas Private Wealth
Arizona
+$10.2K

Top Sellers

1
UBS Group
UBS Group
Switzerland
-$225K
2
NA
NewEdge Advisors
Louisiana
-$222K
3
Citadel Advisors
Citadel Advisors
Florida
-$87.7K
4
Two Sigma Investments
Two Sigma Investments
New York
-$58.9K
5
BFS
Boyer Financial Services
California
-$56.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
IAIM
26
International Assets Investment Management
Florida
$2.62K – – –
Wells Fargo
27
Wells Fargo
California
$302 -$16 -10 -4%
S
28
SignatureFD
Georgia
$296 +$362 +228 New
SS
29
SBI Securities
Japan
$264 – – –
Group One Trading
30
Group One Trading
Illinois
$231 – – –
HNB
31
Hilltop National Bank
Wyoming
$95 – – –
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
$30 – – –
JP Morgan Chase
33
JP Morgan Chase
New York
$29 – – –
CIAM
34
Caitong International Asset Management
Hong Kong
$4 +$5 +3 New
Morgan Stanley
35
Morgan Stanley
New York
$2 -$21 -13 -87%
NA
36
NewEdge Advisors
Louisiana
– -$222K -149,000 Closed
Citadel Advisors
37
Citadel Advisors
Florida
– -$87.7K -58,847 Closed
BFS
38
Boyer Financial Services
California
– -$56.7K -36,817 Closed
Bank of America
39
Bank of America
North Carolina
– -$1.68K -1,126 Closed
BlackRock
40
BlackRock
New York
– -$1.48K -992 Closed
UFPG
41
United Financial Planning Group
New York
– -$373 -250 Closed
Citigroup
42
Citigroup
New York
– -$9 -6 Closed
1
2

MRKR Hedge Fund Activity: Q1 2026 in Review

35 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q1 2026, worth a combined $5.07M — down 16% from $6.03M a quarter earlier.

Fund positioning in MRKR was balanced in Q1 2026: 7 funds opened new positions, 7 closed out, 6 added to existing stakes and 8 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $81.9K. The largest seller was UBS Group, cutting an estimated $225K.

  • 35 institutional investors held Marker Therapeutics (MRKR) as of Q1 2026, down from 36 in Q4 2025.
  • Funds reported $5.07M of Marker Therapeutics stock for Q1 2026, down 16% quarter-over-quarter.
  • 7 funds opened new Marker Therapeutics positions in Q1 2026 and 7 closed out, a net change of 0 holders.
  • The largest Marker Therapeutics buyer in Q1 2026 was Renaissance Technologies, an estimated $81.9K added.
  • The largest Marker Therapeutics seller in Q1 2026 was UBS Group, an estimated $225K sold.

Based on aggregated 13F filings for Q1 2026.